Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

117.48
Delayed Data
As of Jan 13
 +0.40 / +0.34%
Today’s Change
93.05
Today|||52-Week Range
127.00
+1.49%
Year-to-Date
Donald Trump Just Leveled Drug Companies With These 4 Words
Jan 14 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Terra Nova Asset Management LLC Buys Goldman Sachs Group Inc, Ulta Salon Cosmetics & ...
Jan 13 / GuruFocus News - Paid Partner Content
What's Next For Celgene
Jan 10 / MotleyFool.com - Paid Partner Content
Terra Nova Asset Management LLC Buys Goldman Sachs Group Inc, Ulta Salon Cosmetics & ...
Jan 13 / GuruFocus News - Paid Partner Content
Why Agios Pharmaceuticals Sank 34.4% in 2016
Jan 10 / MotleyFool.com - Paid Partner Content
CT Financial Advisors LLC Buys Alphabet Inc, Alphabet Inc, United Therapeutics Corp, ...
Jan 12 / GuruFocus News - Paid Partner Content
Celgene Issues Preliminary 2016 Results, Lifts 2017 View
Jan 10 / Zacks.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
Is Celgene Simply the Best Biotech Stock on the Planet?
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close117.08
Today’s open117.15
Day’s range116.82 - 118.70
Volume3,548,478
Average volume (3 months)4,510,243
Market cap$91.1B
Dividend yield--
Data as of 01/13/2017

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+25.67%
Earnings growth (next 5 years)+21.22%
Revenue growth (last year)+16.47%
P/E ratio44.7
Price/Sales11.10
Price/Book15.61

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.33-0.58%
GSKGlaxoSmithKline+0.21+0.54%
LLYEli Lilly and Co+0.25+0.32%
ABBVAbbVie+0.71+1.16%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$1.59
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs